These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 571022)

  • 1. Molecular weight determination of commercial heparin sodium USP and its sterile solutions.
    Rodriguez HJ; Vanderwielen AJ
    J Pharm Sci; 1979 May; 68(5):588-91. PubMed ID: 571022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid molecular size characterization of heparins by high pressure liquid chromatography.
    Sugisaka N; Petracek FJ
    Fed Proc; 1977 Jan; 36(1):89-92. PubMed ID: 556606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of anticoagulant activity of heparin].
    Dalmora SL; Assaf GS; Dalmora ME; Vaucher LC; Vaccari SF
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(2):59-62. PubMed ID: 1843369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Weights of Bovine and Porcine Heparin Samples: Comparison of Chromatographic Methods and Results of a Collaborative Survey.
    Bertini S; Risi G; Guerrini M; Carrick K; Szajek AY; Mulloy B
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28753946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Heparins Derived From Bovine Tissues and Comparison to Porcine Intestinal Heparins.
    St Ange K; Onishi A; Fu L; Sun X; Lin L; Mori D; Zhang F; Dordick JS; Fareed J; Hoppensteadt D; Jeske W; Linhardt RJ
    Clin Appl Thromb Hemost; 2016 Sep; 22(6):520-7. PubMed ID: 27084870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractionation and structural features of two heparin families with high antithrombotic, antilipemic and anticoagulant activities.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP; Casu B; Torri G
    Arzneimittelforschung; 1985; 35(8):1215-9. PubMed ID: 4074437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparins from porcine and bovine intestinal mucosa: Are they similar drugs?
    Aquino RS; Pereira MS; Vairo BC; Cinelli LP; Santos GR; Fonseca RJ; Mourão PA
    Thromb Haemost; 2010 May; 103(5):1005-15. PubMed ID: 20216993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant activities of lung and mucous heparins.
    Barrowcliffe TW; Johnson EA; Eggleton CA; Thomas DP
    Thromb Res; 1978 Jan; 12(1):27-36. PubMed ID: 644557
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on a highly active anticoagulant fraction of high molecular weight isolated from porcine sodium heparin.
    Sache E; Maillard M; Bertrand H; Maman M; Kunz M; Choay J; Fareed J; Messmore H
    Thromb Res; 1982 Mar; 25(6):443-58. PubMed ID: 7112506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo effects of low molecular weight heparins on experimental thrombosis and bleeding.
    Hirsh J
    Haemostasis; 1986; 16(2):82-6. PubMed ID: 3710297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heterogeneity of heparins.
    Lasker SE
    Fed Proc; 1977 Jan; 36(1):92-7. PubMed ID: 556607
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulant activity of two commercially available heparin preparations. A controlled study.
    Gomez-Perez F
    J Clin Pharmacol New Drugs; 1972 Oct; 12(10):413-6. PubMed ID: 4484532
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterogeneity of unfractionated heparins studied in connection with species, source, and production processes.
    Bianchini P; Liverani L; Mascellani G; Parma B
    Semin Thromb Hemost; 1997; 23(1):3-10. PubMed ID: 9156404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant activity of beef and hog mucosal heparins.
    Aiach M; Kher A; Michaud A; Mardiguian J; Trillou M; Leclerc M
    Thromb Res; 1979 Jan; 14(1):167-77. PubMed ID: 371063
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical characteristics of anionic density-fractionated mucosal heparins in relation to potencies in anticoagulant and thrombin-inhibition assays.
    Hurst RE; van Dedem G; Settine JM
    Thromb Res; 1981 Jun 1-25; 22(5-6):633-43. PubMed ID: 7302907
    [No Abstract]   [Full Text] [Related]  

  • 18. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
    Takahashi HK; Nader HB; Dietrich CP
    Arzneimittelforschung; 1985; 35(11):1620-3. PubMed ID: 4091864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of anticoagulant activity of two preparations of purified heparin.
    Baltes BJ; Diamond S; D'Agostino RJ
    Clin Pharmacol Ther; 1973; 14(2):287-90. PubMed ID: 4735188
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of gamma radiation on the molecular weight and the anticoagulant activity of heparin.
    Chawla AS; Hayward C
    Pharmacology; 1980; 20(4):224-8. PubMed ID: 7384201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.